CONTROL OF ALLOGENIC NK CELL LYSIS BY LECTIN RECEPTORS
CONTROL OF ALLOGENIC NK CELL LYSIS BY LECTIN RECEPTORS
批准号:
6362375
负责人:
JAMES C RYAN
金额:
$27.72万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-03-01 至 2004-02-29
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from the applicant's abstract) The goal of the
project described in this application is to define the receptor systems
controlling the recognition of MHC I by rat NK cells. Functional studies
show that rat NK cells must express MHC-binding receptors inhibits
(allo-inhibition) or activates (allo-activation) natural killing. T
identify these receptors, the investigators have localized the genes
controlling NK cell alloresponses near or within the Ly-49 locus of
lectin-like receptors on rat chromosome 4. They have shown that NK cells
form rats that are defective in alloactivation are also deficient in
Ly-49 expression. They have cloned and sequenced 5 members of the rat
Ly-49 family and have raised mAbs reactive against 2 Ly-49 proteins.
They have also produced new mAbs against receptors implicated in NK cell
alloresponses, and they have cloned these receptor cDNAs. One receptor
(STOK1/2) is a novel L-49 molecule, and the others comprise a previously
undescribed family of NK lectins, which they have termed STOK9.Their
objective is to show that the Ly-49 and STOK9 receptors control NK cell
allo-inhibition and allo-activation in rats. Toward this end they have
5 specific aims. 1] Expand the panel of Ly-49 antibodies for use in
Ly-49 functional studies. 2] Using blocking or stimulating anti-Ly-49
mAbs, they will examine the MHC specificities of each Ly-49 on rat NK
cells and on Ly-49-transfected RNK-16 cell lines. 3] They will clone
cDNAs encoding new members of the STOK9 family. 4] They will produce
mAbs specific for newly cloned STOK9 proteins. 5] As in Aim 2, they will
use these reagents to examine the MHC specificities of STOK9 receptors
on rat NK cells and on STOK9-transfected RNK-16 cell lines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of effective innate immunity in HCV treatment
-
批准号:8376377
-
项目类别:
-
资助金额:$34.75万
-
财政年份:2012
-
负责人:JAMES C RYAN
-
依托单位:
Mechanisms of effective innate immunity in HCV treatment
-
批准号:7919825
-
项目类别:
-
资助金额:$17.2万
-
财政年份:2010
-
负责人:JAMES C RYAN
-
依托单位:
HCV resolution correlates with patterned KIR expressions on lymphocytes.
-
批准号:8088134
-
项目类别:
-
资助金额:$40.53万
-
财政年份:2010
-
负责人:JAMES C RYAN
-
依托单位:
HCV resolution correlates with patterned KIR expressions on lymphocytes.
-
批准号:8293421
-
项目类别:
-
资助金额:$40.29万
-
财政年份:2010
-
负责人:JAMES C RYAN
-
依托单位:
Bay Area Hepatitis C Cooperative Research Center
-
批准号:8666621
-
项目类别:
-
资助金额:$72.52万
-
财政年份:2010
-
负责人:JAMES C RYAN
-
依托单位:
HCV resolution correlates with patterned KIR expressions on lymphocytes.
-
批准号:7889750
-
项目类别:
-
资助金额:$40.9万
-
财政年份:2010
-
负责人:JAMES C RYAN
-
依托单位:
HCV resolution correlates with patterned KIR expressions on lymphocytes.
-
批准号:8466277
-
项目类别:
-
资助金额:$38.42万
-
财政年份:2010
-
负责人:JAMES C RYAN
-
依托单位:
CONTROL OF ALLOGENIC NK CELL LYSIS BY LECTIN RECEPTORS
-
批准号:2736488
-
项目类别:
-
资助金额:$26.13万
-
财政年份:1999
-
负责人:JAMES C RYAN
-
依托单位:
CONTROL OF ALLOGENIC NK CELL LYSIS BY LECTIN RECEPTORS
-
批准号:6163966
-
项目类别:
-
资助金额:$26.91万
-
财政年份:1999
-
负责人:JAMES C RYAN
-
依托单位:
CONTROL OF ALLOGENIC NK CELL LYSIS BY LECTIN RECEPTORS
-
批准号:6511155
-
项目类别:
-
资助金额:$28.55万
-
财政年份:1999
-
负责人:JAMES C RYAN
-
依托单位:
CONTROL OF ALLOGENIC NK CELL LYSIS BY LECTIN RECEPTORS
-
批准号:6632182
-
项目类别:
-
资助金额:$29.41万
-
财政年份:1999
-
负责人:JAMES C RYAN
-
依托单位:
MOLECULAR ACTIVATION OF NK CELLS THROUGH NKR-P1
-
批准号:3460849
-
项目类别:
-
资助金额:$1.76万
-
财政年份:1993
-
负责人:JAMES C RYAN
-
依托单位:
MOLECULAR ACTIVATION OF NK CELLS THROUGH NKR-P1
-
批准号:2101707
-
项目类别:
-
资助金额:$10.08万
-
财政年份:1993
-
负责人:JAMES C RYAN
-
依托单位:
MOLECULAR ACTIVATION OF NK CELLS THROUGH NKR-P1
-
批准号:2101706
-
项目类别:
-
资助金额:$9.25万
-
财政年份:1993
-
负责人:JAMES C RYAN
-
依托单位:
MOLECULAR ACTIVATION OF NK CELLS THROUGH NKR-P1
-
批准号:2443042
-
项目类别:
-
资助金额:$12.01万
-
财政年份:1993
-
负责人:JAMES C RYAN
-
依托单位:
MOLECULAR ACTIVATION OF NK CELLS THROUGH NKR-P1
-
批准号:2101708
-
项目类别:
-
资助金额:$10.99万
-
财政年份:1993
-
负责人:JAMES C RYAN
-
依托单位:
Mechanisms of effective innate immunity in HCV treatment
-
批准号:8666622
-
项目类别:
-
资助金额:$24.44万
-
财政年份:--
-
负责人:JAMES C RYAN
-
依托单位:
Mechanisms of effective innate immunity in HCV treatment
-
批准号:8282816
-
项目类别:
-
资助金额:$19.74万
-
财政年份:--
-
负责人:JAMES C RYAN
-
依托单位:
Mechanisms of effective innate immunity in HCV treatment
-
批准号:8473773
-
项目类别:
-
资助金额:$26.34万
-
财政年份:--
-
负责人:JAMES C RYAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
CAN/lectin 7信号通路调控棉铃虫对Cry1Ac蛋白的免疫机制解析
-
批准号:32172401
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:魏纪珍
-
依托单位:
血栓调节蛋白lectin区优势突变引起血栓形成的分子机制及其干预措施
-
批准号:81973995
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:唐亮
-
依托单位:
靶向Lectin受体多功能分子探针的构建及其在结直肠癌诊治中的实验研究
-
批准号:81371614
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:贾兵
-
依托单位:
免疫识别因子lectin在鳞翅目寄主昆虫识别寄生蜂为“非我”过程中的作用机制研究
-
批准号:31272091
-
项目类别:面上项目
-
资助金额:85.0万元
-
批准年份:2012
-
负责人:胡建
-
依托单位:
水稻花粉优势表达的L-lectin受体激酶基因OsL-LecRK7的功能研究
-
批准号:31000605
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2010
-
负责人:魏丽勤
-
依托单位:
腰带长体茧蜂胚胎表面Helix pomatia lectin结合蛋白保护其逃避寄主血细胞包囊反应的机制研究
-
批准号:30971964
-
项目类别:面上项目
-
资助金额:36.0万元
-
批准年份:2009
-
负责人:胡建
-
依托单位: